Unlike any other therapeutic approach entertained to date, adenine base editing can fully reverse the primary genetic defect in HGPS, eliminating the production of the pathogenic progerin protein while preserving the normal lamin A protein. This evidence concerns the gene LMNA and Hutchinson-Gilford progeria syndrome.